Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 5, 2003, Pages 485-492

  Koter, Maria ^a   Franiak, Ida ^a   Broncel, Marlena ^a   Chojnowska Jezierska, Julita ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Cholesterol; Erythrocyte; Hypercholesterolemia; Peroxidation; Plasma membrane; Spin labels; Statins

Indexed keywords

16 DOXYLSTEARIC ACID; 5 DOXYLSTEARIC ACID; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE LIPID; PRAVASTATIN; SIMVASTATIN; STEARIC ACID DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MEMBRANE FLUIDITY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTRON SPIN RESONANCE; ERYTHROCYTE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LABORATORY TEST; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIN LABELING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; ELECTRON SPIN RESONANCE SPECTROSCOPY; ERYTHROCYTE MEMBRANE; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; MIDDLE AGED; PRAVASTATIN; SIMVASTATIN; TRIGLYCERIDES;

EID: 0037517155     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-042     Document Type: Article

References (28)

1. Aviram, M., Keidar, S., and Brook, G.J. 1991. Dual effect of lovastatin and simvastatin on LDL-macrophage interaction. Eur. J. Clin. Chem. Clin. Biochem. 29: 657-664.
2. Aviram, M., Rosenblat, M., Bisgaier, C.L., and Newton, R.S. 1998. Atorvastatin and gemfibrozil metabolites, but not the parent drugs are potent antioxidants against lipoprotein oxidation. Atherosclerosis, 138: 271-280.
3. Beaumont, J.L., Carlson, L.A., Cooper, G.R., Fejfar, Z., Fredrickson, D.S., and Strasser, T. 1970. Classification of hyperlipidemia and hyperlipoproteinemia. Bull. World Health Organ. 43: 891-915.
4. Bokoch, G.M., and Prossnitz, V. 1992. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells. J. Clin. Invest. 89: 402-408.
5. Bredie, S.J., de Bruin, T.W., and Demacker, P.N. 1995. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B containing lipoproteins, low-density lipoprotein subfraction profile, and low-density oxidizability. Am. J. Cardiol. 75: 348-353.
6. Chabanel, A., Flamm, M., Sung, K.L.P., Lee, M.M., Schachter, D., and Chien S. 1983. Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys. J. 44: 171-176.
7. Dodge, J.T., Mitchell, C., and Hanahan, D.J. 1963. Preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. 100: 119-130.
8. Drabkin, D.L. 1946. The crystallographic and optical properties of the haemoglobin of man in comparison with those of other species. J. Biol. Chem. 164: 703-723.
9. Dwight, J.F., Mendes Ribeiro A.C., and Hendry B.M. 1996. Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition. Clin. Chim. Acta, 256: 53-63.
10. Fenton, J.W., Shen, G.X., Minnear, F.L., Brezniak, D.V., Walenga, J.M., Bognacki, J.J., and Ofosu, F.A. 2000. Statins induce hypothrombotic states? Clin. Appl. Thromb. Hemost. 6(1): 18-21.
11. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
12. Girona, J., La Ville, A.E., and Sola, R. 1999. Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am. J. Cardiol. 83: 846-851.
13. Giroux, L.M., Davignon, J., and Naruszewicz, M. 1993. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte derived macrophages. Biochim. Biophys. Acta, 1165: 335-338.
14. Hussein, O., Schlezinger, S., and Rosenblat, M. 1997. Reduced susceptibility of LDL to lipid peroxidation after fluwastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis, 128: 11-18.
15. Kleinveld, H.A., Demacker, P.N., and de Haan, A.F. 1993. Decreased in vitro oxidizability of low density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Eur. J. Clin. Invest. 23: 289-295.
16. Klyszejko-Stefanowicz, L. 1995. Cytobiochemia. Wydawnictwo Naukowe PWN, Warsaw, Poland.
17. Lijnen, P., Celis, H., and Fagard, R. 1994. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. J. Hypertens. 12: 59-64.
18. Lopez, S., Peiretti, F., Bonardo, B., Juhan-Vague, I., and Nalbone, G. 2000. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis, 152: 359-366.
19. Lowry, O.H., Rosebrough, A., Farr, L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-272.
20. Martinez, M., Vaya, A., Marti, R., Gil, L., Lluch, I., Carmena, R., and Aznar J. 1996. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin. Thromb. Res. 83: 375-388.
21. Nakashima, A., Ohtawa, M., and Masuda, N. 1999. Antioxidative effects of fluvastatin and its major metabolites. YakugakuZasshi, 119: 93-99.
22. Rabini, R.A., Polenta, M., and Staffolani, R. 1993. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes. Exp. Mol. Pathol. 59: 51-57.
23. Riessen, R., Axel, D.I., Fenchel, M., Herzog, U.U., Rossmann, H., and Karsh, K.R. 1999. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Basic Res. Cardiol. 94: 322-332.
24. Rodriguez-Vico, F., Martinez-Cayuela, M., Zafra, M.F., Garcia-Peregrin, E., and Ramirez, H. 1991. A procedure for the simultaneous determination of lipid and protein in biomembranes and other biological samples. Lipids, 26: 77-80.
25. Simon, E., Paul, J.L., Atger, V., Simon, A., and Moatti, N. 1998. Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis, 138: 375-381.
26. Stocks, J., and Dormandy, T.L. 1971. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 20: 95-111.
27. Schreier, S., Polnaszek, C., and Smith I. 1978. Spin labels in membranes. Biochim. Biophys. Acta 515: 375-436.
28. Traber, M.G., and Kayden. H.J. 1984. Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages. Atherosclerosis, 52: 1-11.